FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 141 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,990,000 | +199.0% | 951,871 | +3.3% | 0.00% | – |
| Q2 2022 | $6,351,000 | -75.6% | 921,725 | -67.1% | 0.00% | -100.0% |
| Q1 2022 | $26,060,000 | +1.7% | 2,802,149 | +55.4% | 0.00% | 0.0% |
| Q4 2021 | $25,634,000 | -24.2% | 1,802,670 | +23.6% | 0.00% | -50.0% |
| Q3 2021 | $33,811,000 | -37.5% | 1,458,000 | -32.9% | 0.00% | -33.3% |
| Q2 2021 | $54,120,000 | +3.2% | 2,174,375 | +16.2% | 0.00% | 0.0% |
| Q1 2021 | $52,442,000 | +75.7% | 1,871,595 | +118.8% | 0.00% | +50.0% |
| Q4 2020 | $29,853,000 | +184.8% | 855,375 | +306.7% | 0.00% | +100.0% |
| Q3 2020 | $10,483,000 | – | 210,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |